Oxford Biotrans Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.97M
Latest Deal Amount
  • Investors
  • 7

Oxford Biotrans General Information

Description

Provider of a proprietary enzyme platform intended to develop and commercialize enzymatic process technologies that yield high-value chemical compounds. The company's platform commercializes new enzymatic routes to innovative specialty chemicals based on its patented cytochrome P450 enzyme technology, enabling users to avail environmentally friendly products producing less chemical waste and using less energy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Other Industries
Agricultural Chemicals
Biotechnology
Primary Office
  • 127 Olympic Avenue
  • Milton Park
  • Oxfordshire OX14 4SA
  • England, United Kingdom
+44 07852 000000

Oxford Biotrans Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Biotrans Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 12-Aug-2019 $1.97M 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 10-Oct-2017 00.000 00.000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 04-Aug-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Seed Round 22-Jan-2014 $1.32M $1.32M 00.000 Completed Generating Revenue
1. Seed Round Completed Startup
To view Oxford Biotrans’s complete valuation and funding history, request access »

Oxford Biotrans Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary A 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Seed Preferred 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Seed Preferred 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary A 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Seed Preferred 7,378 $0.012319 $335.07 $335.07 1x $335.07 25.47%
Seed Preferred 4,000 $0.012319 $246.37 $246.37 1x $246.37 13.81%
To view Oxford Biotrans’s complete cap table history, request access »

Oxford Biotrans Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of a proprietary enzyme platform intended to develop and commercialize enzymatic process technologies that yiel
Specialty Chemicals
Oxfordshire, United Kingdom
8 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

00000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
000000000000 000000000
Berkeley, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Biotrans Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
00000 Venture Capital-Backed Berkeley, CA 00 000.00 000000000 - 000.00
00000000000000 Venture Capital-Backed Shfar-Am, Israel 00 000.00 0000000000 0 000.00
0000 0000000 00000 Corporation Buffalo, NY 00 000.00 000000000 000.00
00 0000000000000 ( Formerly VC-backed Houston, TX 00 0000 000000&0 0000
You’re viewing 5 of 10 competitors. Get the full list »

Oxford Biotrans Executive Team (2)

Name Title Board Seat Contact Info
Jason King Ph.D Board Member & Chief Executive Officer
Luet Wong Ph.D Founder & Scientific Advisor
To view Oxford Biotrans’s complete executive team members history, request access »

Oxford Biotrans Board Members (8)

Name Representing Role Since
George Robinson Self Board Member 000 0000
James Mallinson Oxford Spin-out Equity Management Board Observer 000 0000
Jason King Ph.D Oxford Biotrans Board Member & Chief Executive Officer 000 0000
Robert Bahns Touchstone Innovations Board Member 000 0000
Steve Silvey Self Board Observer 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Oxford Biotrans Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Biotrans Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perivoli Innovations Trust Other Minority 000 0000 000000 0
De Monchy Aromatics Corporation Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Oxford Investment Consultants Venture Capital Minority 000 0000 000000 0
University of Oxford Endowment Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »